NCT04380753 - AMG 510 Ethnic Sensitivity Study (CodeBreaK 105). | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

June 16, 2026

Conditions

Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation

Interventions

DRUG

AMG 510

Subjects will be enrolled and will receive AMG 510 PO QD.

Trial Locations (4)

National Taiwan University Hospital, Taipei

Veterans General Hospital - Taichung, Taichung

University of Hong Kong, Queen Mary Hospital, Hong Kong

Prince of Wales Hospital, Shatin, New Territories